BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wilcox RA. Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011;86:928-48. [DOI: 10.1002/ajh.22139] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Mann KP. Molecular Pathology of Malignant Lymphoma. Surg Pathol Clin 2012;5:879-902. [PMID: 26838507 DOI: 10.1016/j.path.2012.08.005] [Reference Citation Analysis]
2 Nakai N, Hagura A, Yamazato S, Katoh N. Mycosis fungoides palmaris et plantaris successfully treated with radiotherapy: Case report and mini-review of the published work. J Dermatol 2014;41:63-7. [DOI: 10.1111/1346-8138.12308] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
3 Johnson LDS, Banerjee S, Kruglov O, Viller NN, Horwitz SM, Lesokhin A, Zain J, Querfeld C, Chen R, Okada C, Sawas A, O'Connor OA, Sievers EL, Shou Y, Uger RA, Wong M, Akilov OE. Targeting CD47 in Sézary syndrome with SIRPαFc. Blood Adv 2019;3:1145-53. [PMID: 30962222 DOI: 10.1182/bloodadvances.2018030577] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 17.0] [Reference Citation Analysis]
4 Wilcox RA. Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 2016;91:151-65. [PMID: 26607183 DOI: 10.1002/ajh.24233] [Cited by in Crossref: 72] [Cited by in F6Publishing: 60] [Article Influence: 10.3] [Reference Citation Analysis]
5 Ogunrinade O, Ahn CS, Gergis U, Yassin AH, Magro C. Cutaneous lymphocyte antigen expression loss and PD1 positivity in early cutaneous lesions of rapidly progressive mycosis fungoides. Clin Case Rep 2014;2:209-18. [PMID: 25614814 DOI: 10.1002/ccr3.103] [Reference Citation Analysis]
6 Willerslev-Olsen A, Krejsgaard T, Lindahl LM, Litvinov IV, Fredholm S, Petersen DL, Nastasi C, Gniadecki R, Mongan NP, Sasseville D, Wasik MA, Bonefeld CM, Geisler C, Woetmann A, Iversen L, Kilian M, Koralov SB, Odum N. Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma. Blood 2016;127:1287-96. [PMID: 26738536 DOI: 10.1182/blood-2015-08-662353] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 8.3] [Reference Citation Analysis]
7 Wilcox RA. A three-signal model of T-cell lymphoma pathogenesis. Am J Hematol 2016;91:113-22. [PMID: 26408334 DOI: 10.1002/ajh.24203] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
8 Manfè V, Biskup E, Willumsgaard A, Skov AG, Palmieri D, Gasparini P, Laganá A, Woetmann A, Ødum N, Croce CM, Gniadecki R. cMyc/miR-125b-5p signalling determines sensitivity to bortezomib in preclinical model of cutaneous T-cell lymphomas. PLoS One 2013;8:e59390. [PMID: 23527180 DOI: 10.1371/journal.pone.0059390] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
9 Piccinno R, Caccialanza M, Çuka E, Recalcati S. Localized conventional radiotherapy in the treatment of Mycosis Fungoides: our experience in 100 patients. J Eur Acad Dermatol Venereol. 2014;28:1040-1044. [PMID: 23998331 DOI: 10.1111/jdv.12254] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
10 Novelli S, García-muret P, Mozos A, Sierra J, Briones J. Total body-surface area as a new prognostic variable in mycosis fungoides and Sézary syndrome. Leukemia & Lymphoma 2016;57:1060-6. [DOI: 10.3109/10428194.2015.1057894] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Dehghan A, Chu T. Hypopigmentation: mycosis fungoides in disguise. BMJ Case Rep 2014;2014:bcr2014206523. [PMID: 25240006 DOI: 10.1136/bcr-2014-206523] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
12 Imam MH, Shenoy PJ, Flowers CR, Phillips A, Lechowicz MJ. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leuk Lymphoma 2013;54:752-9. [PMID: 23004352 DOI: 10.3109/10428194.2012.729831] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 7.0] [Reference Citation Analysis]
13 Wang T, Feldman AL, Wada DA, Lu Y, Polk A, Briski R, Ristow K, Habermann TM, Thomas D, Ziesmer SC, Wellik LE, Lanigan TM, Witzig TE, Pittelkow MR, Bailey NG, Hristov AC, Lim MS, Ansell SM, Wilcox RA. GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features. Blood 2014;123:3007-15. [PMID: 24497534 DOI: 10.1182/blood-2013-12-544809] [Cited by in Crossref: 104] [Cited by in F6Publishing: 98] [Article Influence: 13.0] [Reference Citation Analysis]
14 Zhu L, Han X, Liu Z, Leng S, Shan N, Lv X, Lu K, Hun S, Wu Y, Liu X. Survival prediction model for patients with mycosis fungoides/Sezary syndrome. Future Oncol 2020;16:2487-98. [PMID: 32746631 DOI: 10.2217/fon-2020-0502] [Reference Citation Analysis]
15 Chang TP, Vancurova I. Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma. Biochim Biophys Acta 2014;1843:2620-30. [PMID: 25089799 DOI: 10.1016/j.bbamcr.2014.07.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
16 Hughes CF, Newland K, Mccormack C, Lade S, Prince HM. Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers: Mycosis fungoides and Sézary syndrome. Australasian Journal of Dermatology 2016;57:182-91. [DOI: 10.1111/ajd.12349] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
17 Chang TP, Poltoratsky V, Vancurova I. Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells. J Immunol 2015;194:2942-53. [PMID: 25681335 DOI: 10.4049/jimmunol.1402610] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
18 Hsi ED, Said J, Macon WR, Rodig SJ, Ondrejka SL, Gascoyne RD, Morgan EA, Dorfman DM, Maurer MJ, Dogan A. Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T/NK-cell lymphomas. A North American PTCL study group project. Am J Surg Pathol 2014;38:768-75. [PMID: 24618604 DOI: 10.1097/PAS.0000000000000188] [Cited by in Crossref: 25] [Cited by in F6Publishing: 6] [Article Influence: 3.1] [Reference Citation Analysis]
19 Devata S, Wilcox RA. Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents. Am J Clin Dermatol 2016;17:225-37. [DOI: 10.1007/s40257-016-0177-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
20 Stahly S, Manway M, Lin CC, Sukpraprut-Braaten S. Pagetoid Reticulosis: A Rare Dermatologic Malignancy Presenting in a Middle-Aged Female. Cureus 2021;13:e18524. [PMID: 34754679 DOI: 10.7759/cureus.18524] [Reference Citation Analysis]
21 Wang T, Lu Y, Polk A, Chowdhury P, Murga-Zamalloa C, Fujiwara H, Suemori K, Beyersdorf N, Hristov AC, Lim MS, Bailey NG, Wilcox RA. T-cell Receptor Signaling Activates an ITK/NF-κB/GATA-3 axis in T-cell Lymphomas Facilitating Resistance to Chemotherapy. Clin Cancer Res 2017;23:2506-15. [PMID: 27780854 DOI: 10.1158/1078-0432.CCR-16-1996] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
22 Wilcox RA. Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol 2017;92:1085-102. [PMID: 28872191 DOI: 10.1002/ajh.24876] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 12.8] [Reference Citation Analysis]
23 Esmailzadeh S, Jiang X. AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders. Oncotarget 2011;2:918-34. [PMID: 22248740 DOI: 10.18632/oncotarget.405] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
24 Wilcox RA. Cutaneous T-cell lymphoma: 2014 Update on diagnosis, risk-stratification, and management: Cutaneous T-Cell Lymphoma. Am J Hematol 2014;89:837-51. [DOI: 10.1002/ajh.23756] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
25 Hamada T, Tada K, Aoyama Y, Iwatsuki K. Necrobiotic features in both cutaneous and lymph node lesions in a patient with interstitial mycosis fungoides. Int J Dermatol 2015;54:e122-5. [DOI: 10.1111/ijd.12078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
26 Elenitoba-Johnson KS, Wilcox R. A new molecular paradigm in mycosis fungoides and Sézary syndrome. Semin Diagn Pathol 2017;34:15-21. [PMID: 28024703 DOI: 10.1053/j.semdp.2016.11.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
27 Boonstra PS, Polk A, Brown N, Hristov AC, Bailey NG, Kaminski MS, Phillips T, Devata S, Mayer T, Wilcox RA. A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas. Am J Hematol 2017;92:1287-94. [PMID: 28842936 DOI: 10.1002/ajh.24895] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
28 Hristov AC, Tejasvi T, A Wilcox R. Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management. Am J Hematol 2021. [PMID: 34297414 DOI: 10.1002/ajh.26299] [Reference Citation Analysis]
29 Hristov AC, Tejasvi T, Wilcox RA. Mycosis fungoides and Sézary syndrome: 2019 update on diagnosis, risk-stratification, and management. Am J Hematol 2019;94:1027-41. [PMID: 31313347 DOI: 10.1002/ajh.25577] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
30 Wong DJ, Rao A, Avramis E, Matsunaga DR, Komatsubara KM, Atefi MS, Escuin-Ordinas H, Chodon T, Koya RC, Ribas A, Comin-Anduix B. Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function. Cancer Immunol Res 2014;2:459-68. [PMID: 24795358 DOI: 10.1158/2326-6066.CIR-13-0188] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
31 Novelli S, Monter A, Pilar García-Muret M, Martino R, Briones J, Sierra J. Discussion on the indication of allogeneic stem cell transplantation for advanced cutaneous T cell lymphomas. Int J Hematol 2019;110:406-10. [PMID: 31317515 DOI: 10.1007/s12185-019-02707-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Novelli S, García-muret P, Sierra J, Briones J. Alemtuzumab treatment for Sézary syndrome: A single-center experience. Journal of Dermatological Treatment 2016;27:179-81. [DOI: 10.3109/09546634.2015.1086479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
33 Olszewska B, Sokołowska-Wojdyło M, Lakomy J, Nowicki RJ. The ambiguous pruritogenic role of interleukin-31 in cutaneous T-cell lymphomas in comparison to atopic dermatitis: a review. Postepy Dermatol Alergol 2020;37:319-25. [PMID: 32792870 DOI: 10.5114/ada.2020.96260] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
34 Reneau JC, Wilcox RA. Novel therapies targeting cutaneous T cell lymphomas and their microenvironment. Semin Hematol 2021;58:103-13. [PMID: 33906720 DOI: 10.1053/j.seminhematol.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Kruglov O, Johnson LDS, Minic A, Jordan K, Uger RA, Wong M, Sievers EL, Shou Y, Akilov OE. The pivotal role of cytotoxic NK cells in mediating the therapeutic effect of anti-CD47 therapy in mycosis fungoides. Cancer Immunol Immunother 2021. [PMID: 34519839 DOI: 10.1007/s00262-021-03051-x] [Reference Citation Analysis]
36 Woo J, Baumann A, Arguello V. Recent advancements of flow cytometry: new applications in hematology and oncology. Expert Review of Molecular Diagnostics 2013;14:67-81. [DOI: 10.1586/14737159.2014.862153] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
37 Phillips T, Devata S, Wilcox RA. Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders. J Immunother Cancer 2016;4:95. [PMID: 28031823 DOI: 10.1186/s40425-016-0201-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
38 McClain CM, Cole MB, Robbins JB, Kantrow SM. Mycosis fungoides involving an acrochordon: a case report. J Cutan Pathol 2012;39:1131-4. [PMID: 22994930 DOI: 10.1111/cup.12009] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Hanel W, Briski R, Ross CW, Anderson TF, Kaminski MS, Hristov AC, Wilcox RA. A retrospective comparative outcome analysis following systemic therapy in M ycosis fungoides and S ezary syndrome. Am J Hematol 2016;91:E491-5. [DOI: 10.1002/ajh.24564] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
40 Quéreux G, Brocard A, Saint-Jean M, Peuvrel L, Knol AC, Allix R, Khammari A, Renaut JJ, Dréno B. Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature. J Am Acad Dermatol 2013;69:890-7. [PMID: 24041738 DOI: 10.1016/j.jaad.2013.07.047] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
41 Sandlund JT, Perkins SL. Uncommon non-Hodgkin lymphomas of childhood: pathological diagnosis, clinical features and treatment approaches. Br J Haematol 2015;169:631-46. [PMID: 25851546 DOI: 10.1111/bjh.13359] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Shaum K, Aycock J. Cutaneous T-cell lymphoma with nasal necrosis. Arch Plast Surg 2015;42:259-61. [PMID: 25798408 DOI: 10.5999/aps.2015.42.2.259] [Reference Citation Analysis]
43 Wells CE, Bhaskara S, Stengel KR, Zhao Y, Sirbu B, Chagot B, Cortez D, Khabele D, Chazin WJ, Cooper A, Jacques V, Rusche J, Eischen CM, McGirt LY, Hiebert SW. Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma. PLoS One 2013;8:e68915. [PMID: 23894374 DOI: 10.1371/journal.pone.0068915] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
44 Wei T, Biskup E, Gjerdrum LM, Niazi O, Ødum N, Gniadecki R. Ubiquitin-specific protease 2 decreases p53-dependent apoptosis in cutaneous T-cell lymphoma. Oncotarget 2016;7:48391-400. [PMID: 27351221 DOI: 10.18632/oncotarget.10268] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]